Heze Development Zone chuangli Chemical Co., Ltd.

Heze Development Zone chuangli Chemical Co., Ltd.

Current Location: HOME >> Product
Product Categories
Country: China
Tel: 0530-+86-530-529 6766,+86-15666160102
Mobile: 15666160102
E-mail:
QQ:
Skype: Chat Now!
Product Name MF CAS Details
CH6953755 C26H22F2N6O4S 2055918-71-1 Details
NS-3-008(HCl) C14H24ClN3 1172854-54-4 Details
MAC-545496 C18H18ClN5O3S 838810-96-1 Details
BO-264 C18H19N5O3 2408648-20-2 Details
ODM-201 C19H19ClN6O2 1297538-32-9 Details
ML-109 C31H29N3O5 1186649-91-1 Details
TH5487 C19H18BrIN4O2 2304947-71-3 Details
C75 C14H22O4 191282-48-1 Details
2-BROMO-5-METHOXYBENZONITRILE C8H6BrNO 138642-47-4 Details
2-CHLORO-5-NITROPYRIMIDIN-4-AMINE C4H3ClN4O2 1920-66-7 Details
4-Chloropyridine-2-carboxamide C6H5ClN2O 99586-65-9 Details
3-(4-CHLOROPHENYL)PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER C15H21ClN2O2 886767-49-3 Details
5-Pyrimidinecarboxylic acid, 1,4-dihydro-4-oxo- (9CI) C5H4N2O3 65754-04-3 Details
TAK 632 C27H18F4N4O3S 1228591-30-7 Details
PF 02341066 hydrochloride C21H23Cl3FN5O 1415560-69-8 Details
Inarigivir (ORI-9020, SB-9000) C20H26N7O10PS 475650-36-3 Details
ZT-12-037-01 C21H31N5O2 2328073-61-4 Details
HM30181 (Mesylate) C39H40N6O10S 849675-87-2 Details
Entacapone C14H15N3O5 130929-57-6 Details
BAY-8002 C20H14ClNO5S 724440-27-1 Details
NDI-091143 C20H14ClF2NO5S 2375840-87-0 Details
Aurora kinase inhibitor III C21H18F3N5O 879127-16-9 Details
BD1063 HCl C13H19Cl3N2 206996-13-6 Details
R configuration CPI169 Details
V-9302 C34H38N2O4 1855871-76-9 Details
TA 01 C20H12F3N3 1784751-18-3 Details
TA 02 C20H13F2N3 1784751-19-4 Details
AZD3759 C22H23ClFN5O3 1626387-80-1 Details
18-(4-(5,5-difluoro-5H-4l4,5l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-10-yl)phenyl)octadecyl (2-(trimethylammonio)ethyl) phosphat C38H59BF2N3O3P 1250963-36-0 Details
POL1 inhibitor C21H20N6 1822358-25-7 Details
Hydrazinium hydroxide C15H19ClFNO4 1805818-57-8 Details
3-Pyridinecarboxylic acid, 5-chloro-2-methyl- C7H6ClNO2 1092286-30-0 Details
Tert-Butyl1-(4-Bromophenyl)cyclobutylcarbamate C15H20BrNO2 1032350-06-3 Details
2-Amino-4-methoxypyridine C6H8N2O 10201-73-7 Details
1-(4-BROMOPHENYL)CYCLOBUTANECARBOXYLIC ACID C11H11BrO2 151157-49-2 Details
6-Chloropyridazine-3-carboxylic acid C5H3ClN2O2 5096-73-1 Details
RGD(DY)K, RGD cyclic peptide Details
1-(4-nitrophenyl)cyclobutan-1-amine C10H12N2O2 1260672-25-0 Details
1-(4-BROMOPHENYL)CYCLOBUTANAMINE (HYDROCHLORIDE) C10H13BrClN 1193389-40-0 Details
5-Chloropyrimidine-2-Carboxylic Acid Methyl Ester C6H5ClN2O2 894797-00-3 Details
METHYL 6-CHLOROPYRIDAZINE-3-CARBOXYLATE C6H5ClN2O2 65202-50-8 Details
RGD(DF)C, RGD cyclic peptide Details
tert-Butyl 1-(4-aMinophenyl)cyclobutylcarbaMate C15H22N2O2 1259224-00-4 Details
RGD(DF)K, RGD cyclic peptide Details
G-KG C16H16 1460-59-9 Details
PTCDI-C4 C40H26N2O4 76372-76-4 Details
3-Nitrodibenzofuran C12H7NO3 5410-97-9 Details
N-[3-[[5-Fluoro-2-[[4-[(2-methoxyethoxy)methoxy]phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide C23H24FN5O4 1616380-54-1 Details
3-AMINODIBENZOFURAN C12H9NO 4106-66-5 Details
5-(1H-Indol-3-ylmethyl)imidazolidine-2,4-dione C12H11N3O2 21753-16-2 Details
RARECHEM AL BF 0184 C11H9NO2 21233-61-4 Details
5-nitro-2-methylbenzo[d][1,3]oxazin-4-one C9H6N2O4 412341-84-5 Details
N,N-dimethyl-2-oxo-1,3-dihydroindole-5-sulfonamide C10H12N2O3S 170565-89-6 Details
(3-BROMOPHENYL)-(6-NITROQUINAZOLIN-4-YL)AMINE C14H9BrN4O2 169205-77-0 Details
P-NITROPHENYL PROPIONATE C9H9NO4 1956-06-5 Details
8-methoxy-2-(di-n-propylamino)tetralin C17H27NO 3897-94-7 Details
1,1'-Biphenyl, 2-iodo-6-methoxy- C13H11IO 84253-78-1 Details
BAY K 8644 C16H15F3N2O4 71145-03-4 Details
LY 2606368 C18H19N7O2 1234015-52-1 Details
3-Iodo-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine C8H10IN5 862730-04-9 Details
2,3-Dihydro-Phenazine C12H8N2O2 19220-18-9 Details
SAR 131675 C18H22N4O4 1433953-83-3 Details
CDKI-73 C15H15FN6O2S2 1421693-22-2 Details
DGY-06-116 C32H33ClN8O2 2556836-50-9 Details
IM156 C13H16F3N5O 1422365-93-2 Details
INCB086550 2378608-10-5 Details
Fmoc-Val-MC-Phe-PAB-Lys(Trt)-ONAla-PAB-OH Details
MC-GGFG 1599490-25-1 Details
2-Pyrrolidinepropanoic acid, 1-[(1,1-dimethylethoxy)carbonyl]-β-methoxy-α-methyl-, (αR,βR,2S)-, compd. with N-cyclohexylcyclohexanamine (1:1) C26H48N2O5 1369427-40-6 Details
Guanosine, N-(2-methyl-1-oxopropyl)-, 2',3'-bis(2-methylpropanoate) C22H31N5O8 56489-75-9 Details
Phe-Lys(Trt)-PAB C41H44N4O3 1116085-99-4 Details
Emixustat Hydrochloride C20H19F2N3O3 942195-55-3 Details
N-(8-Amino-6-fluoro-5-methyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)acetamide C13H15FN2O2 182182-31-6 Details
ADU-S100 ammonium salt C20H27N11O10P2S2 1638750-96-5 Details
4,7,10,13-Tetraoxapentadecanoic acid, 15-amino-, methyl ester C12H25NO6 1263044-69-4 Details
Valnivudine C27H35N3O6*ClH 956483-03-7 Details
Fmoc-Phe-Lys(Boc)-PAB-PNP C49H51N5O11 1646299-50-4 Details
MC-Gly-Gly-Phe C23H28N4O7 1599440-15-9 Details
2-(4-((9S,13S)-9,13-Bis(Tert-Butoxycarbonyl)-18,18-Dimethyl-3,11,16-Trioxo-17-Oxa-2,4,10,12-Tetraazanonadecyl)Phenyl)Acetic Acid C34H54N4O10 1610413-97-2 Details
Fmoc-Phe-Lys(Trt)-PAB C56H54N4O5 1116085-98-3 Details
NV-5138 C7H13F2NO2 2095886-80-7 Details
STING agonist-4 C34H38N12O4 2138300-40-8 Details
VLX600 C17H17N7 1622945-04-3 Details
GSK620 C18H19N3O3 2088410-46-0 Details
Tubulin inhibitor 6 C20H14ClNO2S 105925-39-1 Details
MSAB C15H15NO4S 173436-66-3 Details
1,4-Bis(chloromethyl)-2,5-dimethoxybenzene C10H12Cl2O2 3752-97-4 Details
acetone-[bis-(2-amino-ethyl)-dithioacetal] C7H18N2S2 22907-30-8 Details
SCH 51344 C16H20N4O3 171927-40-5 Details
RH01687 C12 H9 Cl N6 O2 S 302901-13-9 Details
NS-398 C13H18N2O5S 123653-11-2 Details
Rigosertib sodium C21H24NNaO8S 592542-60-4 Details
Emapunil C23H23N5O2 226954-04-7 Details
TRi-1 C12H9ClN2O5S 246020-68-6 Details
(±)-Ibipinabant C23H20Cl2N4O2S 362519-49-1 Details
PFK158 C18H11F3N2O 1462249-75-7 Details
BRD7552 C33H33N3O15 1137359-47-7 Details
Pifithrin-μ C8H7NO2S 64984-31-2 Details
2-azido-2-deoxy-D-mannose C6H11N3O5 97604-58-5 Details
1G244 C29H30F2N4O2 847928-32-9 Details
Product Total: Product Page:
1 2 3 4 5 6 7 8 9